Healthcare provider profile · identity verified

Jeffrey A Johnson, MD

Family Practice · YANKTON, SD · NPI 1750360202

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	413	87
Levothyroxine Sodium	Levothyroxine Sodium	383	71
Rosuvastatin Calcium	Rosuvastatin Calcium	304	66
Lisinopril	Lisinopril	286	57
Amlodipine Besylate	Amlodipine Besylate	241	52
Potassium Chloride	Potassium Chloride	241	42
Eliquis	Apixaban	230	33
Losartan Potassium	Losartan Potassium	213	43
Omeprazole	Omeprazole	209	37
Metformin Hcl	Metformin Hcl	201	41
Furosemide	Furosemide	182	33
Tamsulosin Hcl	Tamsulosin Hcl	164	30
Metoprolol Tartrate	Metoprolol Tartrate	163	30
Gabapentin	Gabapentin	157	28
Allopurinol	Allopurinol	155	28
Pantoprazole Sodium	Pantoprazole Sodium	144	29
Jardiance	Empagliflozin	134	21
Ezetimibe	Ezetimibe	130	34
Metoprolol Succinate	Metoprolol Succinate	123	23
Sertraline Hcl	Sertraline Hcl	123	23
Simvastatin	Simvastatin	108	25
Hydrochlorothiazide	Hydrochlorothiazide	107	23
Mirtazapine	Mirtazapine	91	17
Famotidine	Famotidine	87	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	86	22
Ozempic	Semaglutide	85	suppressed
Pregabalin	Pregabalin	85	13
Alendronate Sodium	Alendronate Sodium	84	17
Fluticasone Propionate	Fluticasone Propionate	84	18
Myrbetriq	Mirabegron	79	suppressed
Tramadol Hcl	Tramadol Hcl	77	18
Trazodone Hcl	Trazodone Hcl	75	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	74	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	68	14
Albuterol Sulfate Hfa	Albuterol Sulfate	62	16
Meloxicam	Meloxicam	62	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	59	11
Duloxetine Hcl	Duloxetine Hcl	58	11
Oxycodone Hcl	Oxycodone Hcl	57	11
Ropinirole Hcl	Ropinirole Hcl	57	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	57	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	55	suppressed
Linzess	Linaclotide	55	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	52	11
Pravastatin Sodium	Pravastatin Sodium	48	11
Baclofen	Baclofen	47	suppressed
Buspirone Hcl	Buspirone Hcl	43	11
Diazepam	Diazepam	42	suppressed
Citalopram Hbr	Citalopram Hydrobromide	41	suppressed
Lorazepam	Lorazepam	41	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	12
Divalproex Sodium Er	Divalproex Sodium	40	suppressed
Clonazepam	Clonazepam	38	suppressed
Glipizide	Glipizide	38	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	37	suppressed
Atenolol	Atenolol	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Warfarin Sodium	Warfarin Sodium	34	suppressed
Finasteride	Finasteride	33	suppressed
Propranolol Hcl	Propranolol Hcl	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Prednisone	Prednisone	30	13
Spironolactone	Spironolactone	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	29	suppressed
Topiramate	Topiramate	27	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	26	suppressed
Diltiazem Hcl	Diltiazem Hcl	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Lithium Carbonate	Lithium Carbonate	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Oxycontin	Oxycodone Hcl	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Rybelsus	Semaglutide	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	12
Azelastine Hcl	Azelastine Hcl	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Alprazolam	Alprazolam	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Fentanyl	Fentanyl	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Kerendia	Finerenone	19	suppressed
Dexlansoprazole Dr	Dexlansoprazole	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	15
Sucralfate	Sucralfate	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Digoxin	Digoxin	17	suppressed
Estradiol	Estradiol	17	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Risperidone	Risperidone	17	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Amoxicillin	Amoxicillin	15	11
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Valsartan	Valsartan	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Carvedilol	Carvedilol	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Torsemide	Torsemide	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Qulipta	Atogepant	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Zafirlukast	Zafirlukast	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Armodafinil	Armodafinil	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Mesalamine Dr	Mesalamine	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error